|
Advisory
Committees
Nature and Basis Statements of Conflict(s)
of Interest for Voting Members of FDA Advisory Committee Members
The Agency is revising its procedures
regarding the disclosure of conflicts of interest and waivers for
voting advisory committee members in order to implement the requirements
of section 795 of Pub. L. No. 109-97 (Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies Appropriations
Act, 2006) (Nov. 10, 2005). This information is being provided as
an interim measure to comply with the requirements of this law.
Joint Meeting of the
Endocrinologic and Metabolic Drugs Advisory Committee and the Advisory
Committee for Pharmaceutical Science
October 4, 2006 Charles Cooney, Ph.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Michael McClung, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Marvin Meyer, Ph.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Robert Tuttle, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Nelson Watts, M.D.
• 18 U.S.C. 208 waiver [pdf]
• Acknowledgement and Consent [pdf]
Page updated:
September 19, 2006
|
|